Observational studyJournal of managed care & specialty pharmacy2018

Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing Chemotherapy.

Lee S Schwartzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.